Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Revimid demonstrates potential in myelodysplastic syndromes

June 5, 2003

Novel VEGFR kinase inhibitors identified by Novartis researchers

June 5, 2003

Potential agent for prostate cancer available for licensing from BTG

June 4, 2003

FeRx opens phase II/III trial of MTC-doxorubicin

June 4, 2003

Mitotic kinesin KSP inhibitors identified at Merck

June 4, 2003

Bayer claims new inhibitors of SPEK kinase and their use in cancer therapy

June 4, 2003

Pharma Mar advances kahalalide F into phase II for liver carcinoma

June 3, 2003

Allos updates operating plan for 2003

June 3, 2003

Amgen and Tularik form oncology collaboration

June 3, 2003

Corixa and GSK enter Bexxar agreement for Canada

June 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...